Article info
PostScript
Letter
Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis
- Correspondence to Professor Christoph Schramm, I. Department of Medicine, Helmut and Hannelore Greve Foundation Chair for Rare Diseases, Martin Zeitz-Centre for Rare Diseases, Martinistr. 52, Hamburg 20246, Germany; c.schramm{at}uke.de
Citation
Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis
Publication history
- Received January 13, 2016
- Accepted February 9, 2016
- First published February 26, 2016.
Online issue publication
June 03, 2016
Article Versions
- Previous version (26 February 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/